BACKGROUND
When metronidazole is used in bismuth-based or proton pump inhibitor-based triple therapy, the cure rate of Helicobacter pylori is usually high. However, metronidazole-resistant H. pylori strains, which are increasing in frequency, are a major cause of failed H. pylori eradication.
AIM
To evaluate the efficacy of non-metronidazole containing bismuth-based triple therapy for H. pylo...
